BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34927854)

  • 1. Metal-Organic Framework Hybrids Aid Metabolic Profiling for Colorectal Cancer.
    Li X; Kulkarni AS; Liu X; Gao WQ; Huang L; Hu Z; Qian K
    Small Methods; 2021 Apr; 5(4):e2001001. PubMed ID: 34927854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
    Di Giovanni N; Meuwis MA; Louis E; Focant JF
    Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
    Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
    Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.
    Zhang C; Zhou S; Chang H; Zhuang F; Shi Y; Chang L; Ai W; Du J; Liu W; Liu H; Zhou X; Wang Z; Hong T
    Dis Markers; 2021; 2021():6858809. PubMed ID: 34917201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer.
    Bhardwaj M; Weigl K; Tikk K; Benner A; Schrotz-King P; Brenner H
    Mol Oncol; 2020 Jan; 14(1):8-21. PubMed ID: 31652396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Plasma-Based Protein Marker Panel for Colorectal Cancer Detection Identified by Multiplex Targeted Mass Spectrometry.
    Jones JJ; Wilcox BE; Benz RW; Babbar N; Boragine G; Burrell T; Christie EB; Croner LJ; Cun P; Dillon R; Kairs SN; Kao A; Preston R; Schreckengaust SR; Skor H; Smith WF; You J; Hillis WD; Agus DB; Blume JE
    Clin Colorectal Cancer; 2016 Jun; 15(2):186-194.e13. PubMed ID: 27237338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
    Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
    BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal Cancer Detection Using Targeted LC-MS Metabolic Profiling.
    Djukovic D; Zhang J; Raftery D
    Methods Mol Biol; 2018; 1765():229-240. PubMed ID: 29589312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study for colorectal carcinoma screening by instant metabolomic profiles using conductive polymer spray ionization mass spectrometry.
    Li C; Li K; Xu X; Qi W; Hu X; Jin P
    Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166210. PubMed ID: 34246751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker discovery study of inflammatory proteins for colorectal cancer early detection demonstrated importance of screening setting validation.
    Qian J; Tikk K; Werner S; Balavarca Y; Saadati M; Hechtner M; Brenner H
    J Clin Epidemiol; 2018 Dec; 104():24-34. PubMed ID: 30076979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary metabolomics with machine learning for colorectal cancer detection.
    Kuwabara H; Katsumata K; Iwabuchi A; Udo R; Tago T; Kasahara K; Mazaki J; Enomoto M; Ishizaki T; Soya R; Kaneko M; Ota S; Enomoto A; Soga T; Tomita M; Sunamura M; Tsuchida A; Sugimoto M; Nagakawa Y
    Cancer Sci; 2022 Sep; 113(9):3234-3243. PubMed ID: 35754317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Diagnostic Examination and Prognosis Surveillance by Hierarchical Heterojunction-Assisted Metabolic Analysis.
    Shi F; Zhou J; Wu Y; Hu X; Xie Q; Deng C; Sun N
    Anal Chem; 2022 Jul; 94(29):10497-10505. PubMed ID: 35839420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer.
    Neumann JM; Niehaus K; Neumann N; Knobloch HC; Bremmer F; Krafft U; Kellner U; Nyirády P; Szarvas T; Bednarz H; Reis H
    Lab Invest; 2021 Sep; 101(9):1281-1288. PubMed ID: 34021261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry.
    Nishiumi S; Kobayashi T; Kawana S; Unno Y; Sakai T; Okamoto K; Yamada Y; Sudo K; Yamaji T; Saito Y; Kanemitsu Y; Okita NT; Saito H; Tsugane S; Azuma T; Ojima N; Yoshida M
    Oncotarget; 2017 Mar; 8(10):17115-17126. PubMed ID: 28179577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-mass-ion discriminant equation: a new concept for colorectal cancer screening.
    Lee JH; Kim KH; Park JW; Chang HJ; Kim BC; Kim SY; Kim KG; Lee ES; Kim DY; Oh JH; Yoo BC; Kim IH
    Int J Cancer; 2014 Apr; 134(8):1844-53. PubMed ID: 24096867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling the metabolic disorder and detection of colorectal cancer based on targeted amino acids metabolomics.
    Yang Y; Wang Z; Li X; Lv J; Zhong R; Gao S; Zhang F; Chen W
    J Transl Med; 2023 Nov; 21(1):824. PubMed ID: 37978537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplexed nanomaterial-assisted laser desorption/ionization for pan-cancer diagnosis and classification.
    Zhang H; Zhao L; Jiang J; Zheng J; Yang L; Li Y; Zhou J; Liu T; Xu J; Lou W; Yang W; Tan L; Liu W; Yu Y; Ji M; Xu Y; Lu Y; Li X; Liu Z; Tian R; Hu C; Zhang S; Hu Q; Deng Y; Ying H; Zhong S; Zhang X; Wang Y; Wang H; Bai J; Li X; Duan X
    Nat Commun; 2022 Feb; 13(1):617. PubMed ID: 35105875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Urinary Metabolic Biomarkers of Human Colorectal Cancer.
    Zhu C; Huang F; Li Y; Zhu C; Zhou K; Xie H; Xia L; Xie G
    Dis Markers; 2022; 2022():1758113. PubMed ID: 35521635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A plasma microRNA panel for early detection of colorectal cancer.
    Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
    Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer.
    Kim ER; Kwon HN; Nam H; Kim JJ; Park S; Kim YH
    Sci Rep; 2019 Mar; 9(1):4786. PubMed ID: 30886205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.